summit study: safety & efficacy of bezuclastinib in patients with nonadvanced systemic mastocytosis
Published 1 year ago • 254 plays • Length 3:54Download video MP4
Download video MP3
Similar videos
-
3:46
an update on the summit trial: bezuclastinib in non-advanced systemic mastocytosis
-
2:03
the safety and efficacy of avapritinib in patients with advanced systemic mastocytosis
-
2:56
insights into the treatment and management of advanced systemic mastocytosis
-
5:21
systemic mastocytosis: current treatments and emerging targeted agents
-
3:49
bezuclastinib in adult patients with non-advanced systemic mastocytosis: initial results from summit
-
2:37
current approaches to treating systemic mastocytosis
-
4:46
management strategies for advanced systemic mastocytosis
-
1:46
unmet needs and challenges in advanced systemic mastocytosis
-
57:12
haematology webinar series: haematological emergencies
-
36:16
dr. peter vadas - cme presentation: mast cells gone wild - mast cell activation disorders
-
4:51
living with systemic mastocytosis
-
2:14
diagnosis, classification and treatment of systemic mastocytosis
-
1:50
unmet needs and challenges in mastocytosis
-
2:57
preliminary data from the manifest study: pelabresib in combination with ruxolitinib in mf
-
1:27
ongoing trials and novel agents being explored in advanced and indolent systemic mastocytosis
-
1:44
emerging novel agents for the treatment of mastocytosis
-
1:01
phase i study of ruxolitinib plus abemaciclib for patients with myelofibrosis
-
2:15
mars: mutation-adjusted risk score for advanced systemic mastocytosis
-
4:56
ppr criteria for response assessment in advanced sm
-
1:43
ddpcr detects kit d816v mutations with high sensitivity in systemic mastocytosis
-
48:52
systemic mastocytosis
-
1:23
the current treatment landscape for indolent systemic mastocytosis